Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that it will host a conference call on Thursday,...
Antibody Drug Conjugates Industry Report (2024-2032) Featuring Profiles the Top 13 Players - ADC Therapeutics, Astellas Pharma, AstraZeneca, Celldex Therapeutics, Roche & More
October 09, 2024 10:13 ET
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report by Component, Target, Application, End-user, and Region 2024-2032" report has been added to ...
Therapeutics (Biologics, Biosimilars, Small Molecules) Research Report 2024-2030 with Analyst Recommendations - Focus on Personalized Medicine & Targeted therapy with Nanomedicine
October 01, 2024 06:27 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By...
Degrader-Antibody Conjugates (DAC) Landscape Report 2024: Stakeholders, Platform Technologies, Development and Discovery Pipelines and Partnering Deals
September 10, 2024 12:36 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective" report...
Drug Discovery Services Market Forecast to 2030: Discover the Leading Strategic and Regional Growth Trends Major Players are Capitalizing On
August 30, 2024 06:53 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug...
Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - Exclusive Report by Transparency Market Research, Inc.
August 22, 2024 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 22, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global targeted...
Janus Kinase (JAK) Inhibitor Therapeutic Report 2024: Strategic Evaluation of Over 50 Companies and 55+ Pipeline Drugs
August 15, 2024 11:04 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...
India Preclinical CRO Industry Research 2023-2030: High-throughput Screening, Silicon Modeling, and Advanced Imaging Propelling Developments
August 09, 2024 04:38 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical...
Tinnitus Therapeutics Market Research 2024: Comprehensive Insights About 7+ Companies and 8+ Pipeline Drugs
July 31, 2024 09:06 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Tinnitus - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
July 31, 2024 08:30 ET
|
AC Immune SA
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024 morADC combines proprietary brain-penetrant small...